AcademicCME

AcademicCME is a Joint Accredited continuing medical education company
@cardiomet_CE @ckd_ce @onc_ce @ms_cme @migraine_ce @pulmmed_ce @derm_ce

[AcademicCME @academiccme]

Register ~TODAY~ for the Advanced Curriculum for MS Course, presented prior to CMSC 2026 & chaired by Fred Lublin, MD.

This free CE event is both in-person and virtual on Tues, May 26 @ 12 pm EDT @ the Charlotte Convention Center.

For more info and to register, visit: https://t.co/2bpPAH2fCz. #CE #MS #Lublin #CMSC #APP

[World Health Organization (WHO) @WHO]

#Hantavirus cluster linked to cruise ship travel: 
Since 1 April when the boat set sail, of the 147 passengers and crew, 7 people have become ill, among whom 3 have died, 1 is critically ill and 3 are reporting mild symptoms.

Based on the current information, including how hantavirus spreads, WHO assesses the risk to the global population from this event as low.
We are working closely with health authorities from the countries involved and the ship's operators to ensure passengers and crew get the information and support they need.

WHO will continue to monitor the situation and update the risk assessment as more information becomes available.

More information https://t.co/4945xmA0IX

[AHA Science @AHAScience]

Published today, Brain Health Across the Life Span: A Framework for Future Studies A Scientific Statement from the American Heart Association.

📷 Recommendations to optimize brain health

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

Consensus Recommendation: Real World Insights on Attitudes and Treatment of Hyperkalemia ca. 2026 from @MayoProceedings @RPANephrology @GarySingerMD
#Nephpearls

👉 https://t.co/qBWATmz0bL
👉 https://t.co/2qRpZmP9qj

[NEJM @NEJM]

Combined oral contraceptives and hormone-replacement therapy increase the risk of venous thromboembolism, although the absolute risk is low. Transdermal estradiol and micronized progesterone carry lower risk.

Learn more in the Review Article “Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk” by Leslie Skeith, MD, MHPE, and Shannon M. Bates, MDCM, from @ucalgary and @mcmasteru: https://t.co/aJBy0Qga6d

[CMSC @mscare]

Register for free Pre-CMSC Course chaired by Dr. Lublin on Tues May 26 @ 12pm ET, in-person @ Charlotte Convention Center & virtual. Info: https://t.co/vGV8n6ClRK

[Scott Isaacs @scottisaacsmd]

The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors.
https://t.co/xnMLLYA9bR

[cardio-met @cardiomet_CE]

1) Welcome to a new #accredited #tweetorial from @cardiomet_ce! We are continuing our coverage of #ACC26, today with the guidance of internationally renowned #ATTR_CE experts @MasriAhmadMD & @MarthaGrogan1, who will update us on the newest data on #TTR #stabilizers.

[AcademicCME @academiccme]

Register TODAY for the Advanced Curriculum for MS Course, presented prior to CMSC 2026 & chaired by Fred Lublin, MD.

This free CE event is both in-person and virtual on Tues, May 26 @ pm EDT @ the Charlotte Convention Center.

For more info and to register, visit: https://t.co/2bpPAH2fCz. #CE #MS #Lublin #CMSC #APP

[Scott Isaacs @scottisaacsmd]

Using noninvasive tests to stage fibrosis opens the door to truly personalized MASLD and MASH care, allowing us to match lifestyle, incretin based therapies, resmetirom and standard cirrhosis management to each patient’s fibrosis stage, enabling an approach tailored to liver disease severity.
https://t.co/DVMslWhEFl

[AcademicCME @academiccme]

Register TODAY for the Advanced Curriculum for MS Course, presented prior to CMSC 2026 & chaired by Fred Lublin, MD.

This free CE event is both in-person and virtual on Tues, May 26 @ pm EDT @ the Charlotte Convention Center.

For more info and to register, visit: https://t.co/2bpPAH2fCz. #CE #MS #Lublin #CMSC #APP

[NEJM @NEJM]

GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read the full review: https://t.co/SNdSrVXqWJ

[AHA Science @AHAScience]

The 2026 Guideline on the Management of Dyslipidemia was recently published. Here are the top things for geriatric clinicians to know.

[Scott Isaacs @scottisaacsmd]

New MASLD review by Rinella & Sookoian in @NatRevGastroHep outlines a personalized roadmap for #MASH care, integrating metabolic, liver-directed, and lifestyle therapies. With resmetirom & semaglutide available, there is opportunity for combo strategies, biomarkers & precision medicine.
https://t.co/DVMslWicuT

[cardio-met @cardiomet_CE]

1) It's a NEW CE/#CME-#accredited #tweetorial from @cardiomet_ce, LIVE from #ACC26 in #NewOrleans #NOLA! Continuing our series of updates to treatment of acute #PSVT, we are happy to welcome back returning expert author Narendra Singh MD @heartdrsingh, #cardiologist.

[CMSC @mscare]

At CMSC, we’re committed to improving the lives of people affected by MS. This #MSAwarenessMonth, we celebrate the strength of the MS community — advancing care, research & education together. Learn more at https://t.co/2eCWIoNjTO #MultipleSclerosis #CMSC #MSCommunity

[AcademicCME @academiccme]

Register TODAY for the Advanced Curriculum for MS Course, presented prior to CMSC 2026 & chaired by Fred Lublin, MD.

This free CE event is both in-person and virtual on Tues, May 26 @ pm EDT @ the Charlotte Convention Center. For more info and to register, visit: https://t.co/2bpPAH2fCz.

#CE #MS #Lublin #CMSC #APP

[AHA Science @AHAScience]

The 2026 Guideline on the Management of Dyslipidemia was recently published.

Here are the top 10 things for health care professionals to know.

[JAMA @JAMA_current]

#ResistantHypertension affects approximately 10% of patients treated for #hypertension and is associated with increased #cardiovascular mortality compared with controlled blood pressure.

📄 Learn more in this Review: https://t.co/I73lEmuACO

[Scott Isaacs @scottisaacsmd]

Incretin medications act via a distributed gut–brain–islet–adipose–hepatic axis. By differentially recruiting GLP‑1, GIP, glucagon, amylin, and PYY signaling across CNS, islets, adipose tissue, liver, and stomach, multi-receptor agonists modulate energy intake, energy expenditure, and glucose and lipid handling.
https://t.co/6DDgVoLLgv